We are live on
!
Find out more
Vise Technologies Portfolio holdings
AUM
$8.83B
Turnover
36.58%
1-Year Est. Return
27.11%
This Fund
S&P 500
This Quarter
Est. Return
-1.82%
1 Year Est. Return
+27.11%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.09B
AUM Growth
-$12M
(-0.24%)
Cap. Flow
-$12.2M
Cap. Flow
% of AUM
-0.24%
Top 10 Holdings %
Top 10 Hldgs %
26.69%
Holding
1,461
New
–
Increased
–
Reduced
3
Closed
14
Avg Time Held
1.3
years
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
1.2
years
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$5.19M |
| 2 |
Frontier Communications
FYBR
|
+$1.31M |
| 3 |
Amcor
AMCR
|
+$1.21M |
| 4 |
Exact Sciences
EXAS
|
+$1.19M |
| 5 |
Piper Sandler
PIPR
|
+$932K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.26% |
| 2 | Technology | 15.38% |
| 3 | Financials | 8.06% |
| 4 | Consumer Discretionary | 4.73% |
| 5 | Communication Services | 4.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1301
MarketAxess Holdings
MKTX
$5.79B
| $232K | ﹤0.01% |
1,282
| – | – |
2025 Q4
1 quarter
|
|
1302
Daqo New Energy
DQ
$717M
| $232K | ﹤0.01% |
7,874
| – | – |
2025 Q3
2 quarters
|
|
1303
Stantec
STN
$7.89B
| $231K | ﹤0.01% |
2,451
| – | – |
2025 Q3
2 quarters
|
|
1304
iShares US Tech Independence Focused ETF
IETC
$686M
| $231K | ﹤0.01% |
2,276
| – | – |
2025 Q4
1 quarter
|
|
1305
iShares Morningstar Small-Cap Value ETF
ISCV
$671M
| $231K | ﹤0.01% |
3,376
| – | – |
2025 Q4
1 quarter
|
|
1306
Axsome Therapeutics
AXSM
$8.26B
| $231K | ﹤0.01% |
1,266
| – | – |
2025 Q4
1 quarter
|
|
1307
Vanguard Utilities ETF
VPU
$8.16B
| $230K | ﹤0.01% |
1,241
| – | – |
2025 Q4
1 quarter
|
|
1308
West Pharmaceutical
WST
$27.2B
| $229K | ﹤0.01% |
834
| – | – |
2025 Q3
2 quarters
|
|
1309
Lennox International
LII
$12.4B
| $229K | ﹤0.01% |
472
| – | – |
2025 Q2
3 quarters
|
|
1310
Carlyle Group
CG
$13.2B
| $229K | ﹤0.01% |
3,874
| – | – |
2025 Q3
2 quarters
|
|
1311
Magnolia Oil & Gas
MGY
$6.65B
| $229K | ﹤0.01% |
10,452
| – | – |
2025 Q4
1 quarter
|
|
1312
UGI
UGI
$8.15B
| $229K | ﹤0.01% |
6,112
| – | – |
2025 Q4
1 quarter
|
|
1313
PG&E
PCG
$39.2B
| $227K | ﹤0.01% |
14,154
| – | – |
2024 Q4
5 quarters
|
|
1314
Assured Guaranty
AGO
$3.09B
| $227K | ﹤0.01% |
2,530
| – | – |
2025 Q2
3 quarters
|
|
1315
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.8B
| $227K | ﹤0.01% |
2,482
| – | – |
2025 Q4
1 quarter
|
|
1316
DELISTED
Apellis Pharmaceuticals
APLS
| $226K | ﹤0.01% |
9,012
| – | – |
2025 Q4
1 quarter
|
|
1317
Casella Waste Systems
CWST
$5.61B
| $226K | ﹤0.01% |
2,311
| – | – |
2025 Q4
1 quarter
|
|
1318
Toast
TOST
$18.5B
| $226K | ﹤0.01% |
6,363
| – | – |
2025 Q4
1 quarter
|
|
1319
Reynolds Consumer Products
REYN
$4.81B
| $225K | ﹤0.01% |
9,817
| – | – |
2025 Q3
2 quarters
|
|
1320
California Resources
CRC
$4.73B
| $224K | ﹤0.01% |
5,017
| – | – |
2025 Q4
1 quarter
|
|
1321
Rentokil
RTO
$10.6B
| $224K | ﹤0.01% |
7,594
| – | – |
2025 Q4
1 quarter
|
|
1322
HubSpot
HUBS
$11.4B
| $224K | ﹤0.01% |
557
| – | – |
2024 Q4
5 quarters
|
|
1323
Everpure Inc
P
$42.8B
| $224K | ﹤0.01% |
3,336
| – | – |
2025 Q3
2 quarters
|
|
1324
WesBanco
WSBC
$3.59B
| $223K | ﹤0.01% |
6,718
| – | – |
2025 Q4
1 quarter
|
|
1325
Trimble
TRMB
$14.1B
| $223K | ﹤0.01% |
2,847
| – | – |
2025 Q3
2 quarters
|
|
Similar funds
GRQ
Vise Technologies's Q1 2026 Portfolio in Review
As of Q1 2026, Vise Technologies held 1,461 positions worth $5.09B, down 0.24% from $5.1B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 0.96%. Vise Technologies opened no new positions and exited 14, leaving the 1,461-position portfolio largely intact.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 52% a quarter earlier, followed by Technology and Financials.
- Vise Technologies's biggest Q1 2026 reduction was StoneX, cutting an estimated $101K.
- Vise Technologies fully exited AstraZeneca in Q1 2026, selling an estimated $5.19M.
- Vise Technologies's ten largest holdings make up 27% of its $5.09B portfolio in Q1 2026.
- Vise Technologies opened 0 new positions and closed 14 in Q1 2026.
- Vise Technologies's portfolio value fell 0.24% quarter-over-quarter to $5.09B.
Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.